New research found that mRNA vaccines for COVID-19 could enhance cancer treatments and help patients live longer.

Cancer patients who got an mRNA COVID vaccine within a few months of their immunotherapy lived longer than those who did not, health records show.

Mursla Bio, a leader in Extracellular Vesicle (EV) science on a mission to advance precision diagnostics and significantly improve chronic disease outcomes for at-risk patients, today announced a ...

A new mRNA platform targets tumors with precision, limits side effects, and converts immune-silent cancers into responsive ones for stronger treatment outcomes.

Yale researchers have developed a new vaccine that does double duty against a rare and aggressive skin cancer by targeting ...

Reports third quarter revenue of $1.0 billion, GAAP net loss of $(0.2) billion and GAAP EPS of $(0.51) Narrows 2025 projected ...

A presentation by scientists on a work group for the Centers for Disease Control and Prevention’s vaccine advisory panel ...

There's a new frontier in treating autoimmune diseases. Today's treatments tamp down the friendly fire but don't fix what's ...

RNA-based therapeutics are transforming medicine, but scaling production efficiently remains a challenge, particularly the ...

Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...